PF-03715455 is a potent inhaled p38 MAPK inhibitor. PF-03715455 shows some selectivity for p38alpha over p38beta with respective IC50 values of 0.88 and 23 nM. PF-03715455 potently inhibits LPS-induced TNFalpha production in human whole blood (IC50=1.7 nM). PF-03715455 has potential for the treatment of COPD (chronic obstructive pulmonary disease)[1][2].
Molekulargewicht:
700.27
Reinheit:
98.44
CAS Nummer:
[1056164-52-3]
Formel:
C35H34ClN7O3S2
Target-Kategorie:
p38 MAPK
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten